SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HIV Reservoirs and Cure Strategies
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
12 of
12
|
Introduction of Speakers Part 1
5’Leader Defects in HIV Plasma Clones Drive 80% of Persistent Viremia on Long-Term ART (ABSTRACT
100)
Francesco R. Simonetti
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
BACH2-Driven Tissue Resident Memory Programs Promote HIV-1 Persistence (ABSTRACT
101)
Yulong Wei
Yale University, New Haven, CT, USA
Longitudinal Co-Evolution of HIV-1 Reservoir Cells and Immune Effector Cells During Long-Term Art (ABSTRACT
102)
Weiwei Sun
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
AZD5582 and Venetoclax Reduce SIV Reservoirs in ART-Suppressed Macaques (ABSTRACT
103)
Benedicth Ukhueduan
Emory University, Atlanta, GA, USA
Questions and Answers Part 1
Introduction of Speakers Part 2
HIV GAG x CD3 Soluble TCR Bispecific Reduces the Active HIV Reservoir in a Phase I/II Trial (ABSTRACT
104)
Beatriz Mothe
Fundació Lluita contra la SIDA, Badalona, Spain
Evaluation of 2 bNAbs Plus Vesatolimod in Early-Treated South African Women With HIV-1 During ATI (ABSTRACT
105)
Thumbi Ndung'u
Africa Health Research Institute, Mtubatuba, South Africa
A Single Infusion of CCR5-/- CD4 Tscm Cells Promotes Control of SIV Upon ATI (ABSTRACT
106)
Ashish A. Sharma
Emory University, Atlanta, GA, USA
RIO: A Randomised Placebo-Controlled Study of 2 LS-bNAbs in People Treated in Early HIV (ABSTRACT
107)
Sarah Fidler
Imperial College London, London, UK
Questions and Answers Part 2
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
12 of
12
|
